- Home
- ADTN vs MGTX Comparison
ADTN vs MGTX Comparison
Compare ADTN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- MGTX
- Stock Information
- Founded
- ADTN 1985
- MGTX 2015
- Country
- ADTN United States
- MGTX United States
- Employees
- ADTN N/A
- MGTX N/A
- Industry
- ADTN Telecommunications Equipment
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADTN Telecommunications
- MGTX Health Care
- Exchange
- ADTN Nasdaq
- MGTX Nasdaq
- Market Cap
- ADTN 708.5M
- MGTX 670.2M
- IPO Year
- ADTN 1994
- MGTX N/A
- Fundamental
- Price
- ADTN $9.05
- MGTX $7.75
- Analyst Decision
- ADTN Strong Buy
- MGTX Strong Buy
- Analyst Count
- ADTN 5
- MGTX 2
- Target Price
- ADTN $12.80
- MGTX $24.00
- AVG Volume (30 Days)
- ADTN 1.4M
- MGTX 367.2K
- Earning Date
- ADTN 11-03-2025
- MGTX 11-12-2025
- Dividend Yield
- ADTN N/A
- MGTX N/A
- EPS Growth
- ADTN N/A
- MGTX N/A
- EPS
- ADTN N/A
- MGTX N/A
- Revenue
- ADTN $983,368,000.00
- MGTX $37,917,000.00
- Revenue This Year
- ADTN $17.80
- MGTX $144.79
- Revenue Next Year
- ADTN $8.37
- MGTX $168.58
- P/E Ratio
- ADTN N/A
- MGTX N/A
- Revenue Growth
- ADTN 3.52
- MGTX 366.84
- 52 Week Low
- ADTN $6.02
- MGTX $4.55
- 52 Week High
- ADTN $12.44
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- ADTN 47.69
- MGTX 44.45
- Support Level
- ADTN $8.40
- MGTX $7.46
- Resistance Level
- ADTN $9.54
- MGTX $8.56
- Average True Range (ATR)
- ADTN 0.32
- MGTX 0.48
- MACD
- ADTN -0.01
- MGTX -0.07
- Stochastic Oscillator
- ADTN 48.94
- MGTX 20.81
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.